Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00779519 | Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss | PHASE2 | COMPLETED | 100 | — | — | Feb 1, 2009 | - | Jun 27, 2011 | 12 | United States, Canada |
| Arm | Type | Description |
|---|---|---|
| Placebo | PLACEBO_COMPARATOR | - |
| TTP435 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| TTP435 | DRUG | - |
| Placebo | DRUG | - |
Inclusion Criteria: * Male or female volunteers, aged 18 to 65 years, inclusive. * Subjects must be obese (class 1: BMI of 30.0 to 34.9 kg/m2 or class 2: BMI of 35 to 39.9 kg/m2 in non-Asians and BMI of 27.0 - 31.9 kg/m2 or 32.0 - 36.9 kg/m2 in Asians) at the Screening Visit. * Female subjects must...